Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Every million share position will become about a dollar more expensive.....roughly, righty-o, Angelo?
Wait for the bidding war! May be 15 dollar before its over
Rumored IPCI (Intellipharmaceutics) Buyout Offer
Buyout Rumor has been upgraded to $11.50/Share
They did not get them so I pulled em off
my guess is that a fund is taking a position... buyout rumor is BS
Under the terms of the agreement, Allergan will acquire Tobira for an upfront payment of $28.35 per share in cash, and up to $49.84 per share in contingent value rights that may be payable based on the successful completion of certain development, regulatory and commercial milestones, for a total potential consideration of up to $1.695 billion.
doing a NDA-S does allow you to skip phase 1 testing
they need to "prove" that statement and that can be done through the NDA-S pathway. a much shorter timeline than starting over with a new NDA.
Numbers.....you got it!!!!
I wonder if anyone was on the TBRA message board on monday saying 20K shares today makes you a millionaire by the end of the week.
And I wonder how many were saying that it's worth $4.75 because... that's all the street is willing to pay for it!!!
Very nice post... full of out of the box thinking.
But it seems curious to me... coming from someone who advocates "waiting to buy till everyone knows about IPCI"
GREAT DD Fabius!!!
Great find and post Fabius.
As I've said before... TPOAEBILALFITW !!!
The Price Of An Emerging Biotech Is Like A Leaf Fluttering In The Wind.
LOL.
20K shares today makes you a millionaire in 3 to 5 years!!!
Despicable post Z - thanxs.
I would like to know where that came from, and when it was made public.
Link please???
The delay of release of the active substance may be by a time period selected from the group consisting of about 0.5 hours, about 1 hour, about 2 hours, about 3 hours, about 4 hours, about 5 hours, about 6 hours, about 7 hours, about 8 hours, about 9 hours, or about 10 hours.
Of late... being on this MB... rather makes me feel like I'm in "the twilight zone".
You win Samsa... you've worn me out!!!
I'm glad - I think - that you've reached so far into your "twilight years".
The disagreement was never about what they would file... but your insistance that they would file an NDA-S and forego any Phase 1 requirement... which is extremely MISLEADING.
They will have to start from scratch!!!
Please accept that you were mis-informing, so I don't have to start searching through your posts and point out the SEVERAL times that you imply that no Phase 1 would be needed... that it would be stupid to go back to Phase 1, as you expressed.
Those figures are from Jan 2016... so the following figures from the last capital raise would need to be added to those #s
Number of Firm Shares: 3,229,814
Number of Firm Warrants: 1,614,907
Number of Option Shares: 484,472
Number of Option Warrants: 242,236
Roughly a combined ~ 28.0 million shares outstanding
Roughly a combined ~ 8.6 million warrants and options, with an average purchase price of around $3.00 a share, which would bring in ~ $25 million to the company (roughly figured)
If there were a buyout, all options and warrants would be exercised so any buyout offer should use ~ 36.6 as number of shares... NOT THAT I THINK A BUYOUT IS COMING... just a # to use for any figuring.
fisherman... I'm pretty certain PHARMER-GUY is Tony Pro... although in some postings he appears to be more literate than others... I believe I recall that one time he posted that he used his son's computer to post and posted under his son's moniker???
Excellent Doog - thanxs.
My guess is that Oxtenda will take the same path as Rexista did.
Extensive Phase 1 studies going directly to a Phase 3 study consisting of Bio Equivalency data.
We've been claiming that Rexista did/does not need a Phase 3 study... when in fact it did... it simply took the form of BE tests... it relies on objective data rather than a subjective opinion where subjective opinions are known to vary extremely.
Ha Ha Ha - it is true - boy I gatta pat myself on the back for this one... LOL
https://trademarks.justia.com/863/94/oxtenda-86394998.html
Just a wild guess - I will not even say as to where I got it from, but Rexista PODRAS may well already be named...
Oxtenda ODR Overdose Resistant Tablets.
If it's true... I hope they make it public so we can stop with the Rexista PODDS and Rexista PODRAS bull - and it's just Rexista and/or Oxtenda.
You heard it here first folks!!! LOL
Well... I bought a couple of Musky Innovations Heavy Pro Series Magnum Musky Spin rods by mistake... willing to let them go for a good price if anyone wants to make a reasonable offer LOL.
No need to get so upset... Personally, I think it is good news to see IPCI mentioned in this way
BULL
a TOTAL FARCE by some idiot who is not even clever enough to think it through - and proof of that is simply this.
$503,000,000 divided by $9.50 = 52,947,000 shares... they don't have 53 million shares!!!!!!
Fully diluted I believe is only ~ 33 million shares... so IF there was an offer of $9.50 a share then it would be $313.5 million, and if the offer was $503 million then it would be for $15.25
I don't believe IPCI is going to be bought out any time soon.
IPCI is on the CUSP of becoming a powerhouse... in my opinion it's right now worth $6.00 a share but has the potential to be worth considerably more going forward.
The only deal right now would be for say $500 million now AND milestone payments of say $200 million for .... NEVER MIND... IT WOULD JUST BE TOO COMPLEX TO EVALUATE FAIRLY FOR BOTH PARTIES RIGHT NOW.
The Odidi's will decide when to sell and I don't think it will be under $2.5 billion - I'm not saying it is worth that now - but it will be worth that within a few years when the pipeline is more matured... and they will maintain ownership and continue progress until that offer is made!!!
Thanxs Doog - that should add some clarity - but perhaps you would re-send and ask specifically if a Phase 1 will be required... and if he thinks the phase 3 will, as in the Rexista PODDS, consist of BE studies.
the current application will already be enhanced by PODRAS which is why they need the number
http://www.fda.gov/drugs/resourcesforyou/consumers/ucm143534.htm
The above gives a very clear picture of the purpose of the various phases in the trials... and the below gives an in depth view of the process.
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm289601.htm
Pain Medication studies are notoriously fifficult to conduct due to the extremely high placebo effect... as much as 60% at times... another word, give 10 people a sugar pill while telling him it's pain medication and as many as 6 out of 10 will tell you they feel much better.
So I believe that possibly Rexista+PODRAS may well turn out to be primarily objective Bio Equivalency BE studies rather than subjective standard studies.
Give a patient the medication... take and analyze blood samples on an hourly basis... and based on an existing data base you have an objective map of the effect of the drug... although I think it will, never-the-less, be accompanied by the patients subjective response to the drug.
I think the greatest time period will be the Pre-Clinical work to ascertain it will be safe to administer to the 1st patient in the phase 1 safety test... I actually think that once safety has been established... the phase 3 efficacy test will be a breeze, and should take no more than 6 months and will probably be the lesser requirement.
For those who are wondering if something could go wrong that might result in overdose... I'm sure there will be plenty of Naltrexone at the scene... which reverses the effects of opioids.
So what is it that you're saying numbers... that Rexista + PODRAS can simply can simply apply for a supplemental NDA and skip phase 1... or do you think they will be required to do a phase 1???
if the company intends to roll out Enhanced Rexista as a separate drug down the road which would require all the phase 1 and HAL studies and BE etc. which would be stupid when they could have just filed a Supplement.
Great DD Fabius!!!
I just want to clarify Net Sales so it's clear as to why it's different than Gross Sales.
You've probably seen commercials where at the end of it they say that if you can't afford the cost... get in touch with them, or perhaps when the doctor gives you a prescription they also give you a coupon or voucher that allows you a certain amount off the prescription price.
Net Sales = the Selling Price Minus the Coupon Value, so a prescription cost of $100.00 that has a voucher for $30.00 has a Net Sales of $70.00, which is what royalties are paid on.
will they file the NDA knowing they cant meet that obligation of naming the manufacturer because they haven't inked a deal?
Long IPCI- as all things do your own due diligence, buy on facts not emotions, ensure nothing fundamentally changes with the company, and sit back and relax knowing you made a sound choice and good things take time.
As you can see from this level 2 image - you only see the highest bid or lowest ask of each of the MM.
Underneath that ARCA 1.79 bid for 600 shares could be an order for thousands of shares at 1.79 - similarly an order to sell 100K shares could be lurking under those 100 shares at 1.80 ask on NSDQ.
the MM have Level 3 and see ALL the bids and asks at all prices.
At one time I could see all the NSDQ bids and asks but not anymore... I think it was just a glitch in the programming that allowed me to see Level 3 on NSDQ board.
help with images please - I assume you need a storage place where you can download images to be able to post them here... anyone recommend a FREE storage place to transfer pictures to???
do you recall how the Focalin XR approvals were handled???
Were Mylan and the other non first filers given tentative approval on their submissions at the same time Teva and IPCI were given full approval on their fist to file submissions???
Since IPCI is not one of the first filers, my guess is they do not get approval in first round
then you have two choices. file as a new drug starting from square 1 or file an amendment to your previously approved drug and jump directly to phase 3 testing. which do you think a company would do? if you choose go directly to phase 3 then continue.
I'm also not sure they would not need to start with a phase 1 study, as that is the phase which primarily focuses on safety... after all IPCI claims that they can give a lethal dose of the drug without affecting the patient... you don't prove that in phase 3... you prove it, and very slowly and carefully, in phase 1 where you dose 1 person, wait to see results... dose 2 people, wait to see results... dose 4 people etc. etc... luckily, unlike cancer, we don't need to wait months or years to see results - you dose the first patient at night... and if he wakes up in the morning... you're good to go dose the next 2... LOL.
You say "some"??? how many is some, and did someone pay you $2.10 for them???, 33 cents - almost 20% - above closing price???
Whatever made you think you could/would get 20% ABOVE closing price???, that you would put a sell order there???
I don't think those 56K shares trade was an accident or a mistake... and I'm afraid it may be for a sinister purpose... we'll see how the day goes before I express anything further.
??? 56K shares traded at $2.10 at exactly 9:30:00 ???